Christian Schenk

Christian Schenk serves as an Investment Director at Apposite Capital since November 2020, where the focus is on profitable healthcare and life science companies. Additionally, Christian holds roles as a Non-Executive Director and Board Observer for several Apposite Capital investments, including Kelso Pharma, Summit Medical Group Ltd, and Emblation. Prior experience includes working as an Engagement Manager at L.E.K. Consulting from September 2014 to November 2020 and as a Medical Sales Representative at Eli Lilly and Company from November 2011 to February 2014. Christian's background includes a role as a Vaccine Scientist at Valneva and research experience at the Research Institute of Molecular Pathology. Academic qualifications comprise passing CFA Level 1 and 2 from the CFA Institute and a Master of Science in Molecular Biology from the University of Vienna.